GeoVax Labs Inc (GOVX)

[StockLogistics]

The FDA stated SIGA’s Tpoxx has no human data to show it is effective against the current virus.

“Therapeutics

There is no FDA-approved or authorized medicine for the treatment of monkeypox disease; however, TPOXX (tecovirimat), an antiviral medication, is being made available through the CDC under an FDA authority called Expanded Access or “compassionate use.” The FDA continues to work with the CDC to streamline their Expanded Access Program for monkeypox to facilitate access.

There are currently no human data demonstrating the efficacy of TPOXX for the treatment of monkeypox, or the safety and pharmacokinetic profile (which helps us understand what the human body does to a drug). Although expanded access program is available, conducting randomized, controlled trials to assess TPOXX’s safety and efficacy in humans with monkeypox infections is essential.”

https://www.fda.gov/news-events/press-announcements/fda-provides-update-agency-response-monkeypox-outbreak

Their SP dropped from 22 to 14 on the news, it’s not yet a player in this story until and if it can prove effective. Those that bought in at 5.00 at sold at 20, good trade on the rumor that it might work eventually. They can also see that Govx is the market replacement for their ineffectiveness and are trying to hold off selling so they themselves can sell for a profit and jump in to Govx at a lower price ( they hope to cause with tweets ). Supply low and demand high for vaccines, and increasing.